Arab Board Dermatology Final common mistakes
Arab Board Dermatology Final · Understand the traps and how to avoid them.
When shown a photomicrograph described in text (e.g., 'acantholysis with suprabasal clefting and a tombstone row of basal cells'), the candidate names a single diagnosis and stops, rather than first committing to the level of the split and the pattern of inflammation before generating a differential.
Candidates pattern-match the whole image to a memorised diagnosis instead of systematically reading histology in layers (stratum corneum, epidermis, dermoepidermal junction, dermis) and then applying pattern analysis; this collapses under variant or overlapping presentations.
What to do instead
Practise a fixed read-out order for every dermatopathology stem: (1) site of pathology, (2) level of split, (3) cell type and cytology, (4) inflammatory infiltrate composition and distribution, (5) special stains. Then state the top two differentials and the single feature that discriminates them. Do 20 timed unknown-slide vignettes with this template.
On a stem describing a widespread eruption with systemic features, the candidate treats the skin finding as the whole answer and omits the internal workup or the dermatologic emergency step (e.g., does not state urgent fluid/electrolyte management, burn-unit transfer, or the specific malignancy screen).
Training emphasis on morphology rewards naming the rash; candidates under-rehearse the 'what do you do next in the first hour' and 'what systemic associations must I exclude' components, which is where examiners allocate marks.
What to do instead
For every emergency-type diagnosis (SJS/TEN, erythroderma, pemphigus vulgaris, DRESS, necrotising fasciitis, angioedema) rehearse a three-part script: immediate resuscitation/withdrawal, specific investigations, and systemic association screen. Write it out from memory weekly.
The candidate gives a drug name without the dose, route, duration, or monitoring, and without stating what they would do if the patient failed first-line therapy, when asked 'how would you manage this patient'.
Knowledge is stored as drug-diagnosis pairs rather than as treatment algorithms; candidates have not internalised that management questions are marked on structure (general measures, first-line, second-line, monitoring, counselling).
What to do instead
Answer management questions in a fixed scaffold: general/supportive measures, first-line agent with dose and duration, expected response time, second-line options, monitoring and counselling. Rehearse aloud for the ten highest-yield diseases in each domain.
The candidate describes an eruption as 'itchy red rash' or 'scaly plaques' without committing to primary lesion type, distribution, symmetry, and mucosal or nail involvement, then gives a broad differential that ignores the discriminator already present in the stem.
Under time pressure candidates read the stem once and jump to a diagnosis, skipping the deliberate morphological inventory that would have narrowed the differential; descriptive vocabulary is often recalled passively but not used actively.
What to do instead
Before answering any morphology question, write four headings and fill them from the stem: primary lesion, distribution/pattern, mucosal and nail involvement, systemic symptoms. Only then list three differentials and name the one feature that excludes two of them.
The candidate manages a chronic relapsing condition (psoriasis, atopic dermatitis, alopecia areata, vitiligo) as a single acute episode, omitting severity assessment, comorbidity screening, step-up/step-down strategy, and the psychological or quality-of-life dimension.
Textbook learning is organised around diagnosis and first-line treatment; chronic disease models, severity scoring, and comorbidity screening are less frequently tested in undergraduate training and get under-weighted in revision.
What to do instead
For each major chronic disease, memorise a severity tool (PASI, EASI/SCORAD, SALT, VASI), the recognised comorbidities, and a stepwise therapeutic ladder. Practise writing a one-page 'long-term plan' for each, including when to refer and when to consider biologics or systemic therapy.
The candidate interprets a positive serology or a single antibody result as diagnostic on its own (e.g., ANA positivity, anti-desmoglein titre, patch test positivity) without weighting pre-test probability, titre, or the clinical pattern.
Laboratory results feel objective and are easier to recall than Bayesian reasoning; candidates have not been trained to ask 'how much does this test change my probability' and to recognise low-specificity tests in low-prevalence settings.
What to do instead
For every test you plan to order, state its sensitivity, specificity, and the clinical question it answers. Practise interpreting results in context: 'ANA 1:80 in a patient with isolated arthralgia' versus 'in a patient with photosensitive rash and oral ulcers'. Learn which antibodies are specific versus screening.
When a stem describes a child with a rash, the candidate applies the adult differential and adult dosing without adjusting for age-specific diagnoses, age-specific normal variants, or weight-based prescribing.
Adult dermatology dominates clinical exposure and revision; paediatric-specific entities (miliaria, seborrhoeic pattern of infancy, nappy rash mimics, inherited ichthyoses, vascular anomalies) and paediatric pharmacology are comparatively under-rehearsed.
What to do instead
Build a separate paediatric revision list organised by age band (neonate, infant, toddler, school-age, adolescent). For each, note the age-specific differential and the weight-based dose or the reason the adult drug is contraindicated. Test yourself by age band, not by disease category.
The candidate describes a surgical or laser plan without stating lesion selection criteria, margin or depth, anaesthesia, closure technique, expected scar, or the specific consent and complication discussion (e.g., for a pigmented lesion or a keloid-prone site).
Surgical and cosmetic topics are often studied as technique lists rather than as decision algorithms; candidates omit the risk-benefit and consent framing that examiners expect, especially around pigmented lesions and cosmetic procedures.
What to do instead
For each procedure rehearse: indication and contraindication, anaesthesia, technique and margins, closure, expected healing and scar, complications, consent points. Specifically drill the melanoma-suspicious lesion pathway and laser parameter selection by Fitzpatrick type.
The candidate answers a hair or nail question with a single diagnosis (e.g., 'telogen effluvium') without performing the required clinical discriminator (pull test, trichoscopy pattern, nail fold examination, or the timing relationship to a trigger) or without offering the correct investigation (e.g., trichoscopy versus biopsy).
Hair and nail disorders are taught as lists of named conditions with brief descriptions; the bedside manoeuvres that separate them are learned late and are rarely practised under exam conditions.
What to do instead
Learn a short set of manoeuvres (hair pull test, part-width assessment, trichoscopy signs such as exclamation-mark hairs, yellow dots, perifollicular scaling; nail fold capillaroscopy, dermoscopy of the nail matrix) and attach each to the diagnosis it confirms. Rehearse 'which manoeuvre would you do and what would it show' for each entity.
The candidate treats photodermatology and pigmentary disorders as pattern recognition only, failing to state the phototest/photopatch test pathway, the action spectrum, or the photoprotection and camouflage counselling, and failing to distinguish melanocyte number from melanocyte function when classifying pigmentary disease.
These topics are visually memorable but conceptually thin in most revision notes; the investigative pathway and the mechanistic classification (melanopenic versus melanocytic versus dermal pigment) are under-taught.
What to do instead
For photodermatoses, memorise the classification (idiopathic, drug/chemical, genetic, metabolic) and the investigation sequence (history and action spectrum, phototesting, photopatch testing, porphyrins where relevant). For pigmentary disorders, classify each as reduced melanin, absent melanocytes, or dermal pigment, and state the corresponding treatment logic and counselling.